Skip to main content
PMC home page
Annals of Oncology logoLink to Annals of Oncology
. 2016 Mar 3;27(6):1180. doi: 10.1093/annonc/mdw095

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

B H O'Neil, A J Scott, W W Ma, S J Cohen, D L Aisner, A R Menter, M A Tejani, J K Cho, J Granfortuna, A L Coveler, O O Olowokure, J C Baranda, M Cusnir, P Phillip, J Boles, R Nazemzadeh, M Rarick, D J Cohen, J Radford, L Fehrenbacher, R Bajaj, V Bathini, P Fanta, J Berlin, A J McRee, R Maguire, F Wilhelm, M Maniar, A Jimeno, C L Gomes, W A Messersmith
PMCID: PMC6795379  PMID: 26945010

Ann Oncol 2015; 26: 1923–1929 (doi: 10.1093/annonc/mdv264)

In the original article, author A. L. Coveler was incorrectly listed as L. Coveler.

The correct author list is as above.

Articles from Annals of Oncology are provided here courtesy of Oxford University Press

RESOURCES